Propargyl glycine amino propargyl diol compounds for treatment o

Details Propargyl glycine amino propargyl diol compounds for treatment o Propargyl glycine amino propargyl diol compounds for treatment o

1991-10-29

1993-06-29

Shippen, Michael L.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

N-c doai

514255, 514315, 514317, 514357, 514365, 514374, 514378, 514400, 514427, 514428, 514438, 514471, 514478, 514484, 514485, 514517, 514588, 514595, 514601, 514608, 514616, 544400, 546231, 546233, 546332, 546336, 548204, 548235, 548247, 548561, 548568, 5483751, 5483381, 5483385, 549 76, 549 77, 549492, 549496, 558 50, 558 61, 560 13, 560 27, 560 29, 560115, 560148, 560159, 564 32, 564 47, 564 57, 564 86, 564 95, 564 96, 564 97, 564102, 564153, 564154, 564155, 564152, 564159, A61K 3127

Patent

active

052235351

ABSTRACT:
Compounds characterized generally as propargyl glycine amino propargyl diol derivatives are useful as renin inhibitors for the treatment of hypertension. Compounds of particular interest are those of Formula I ##STR1## wherein A is selected from CO and SO.sub.2 wherein X is selected from oxygen atom and methylene; wherein each of R.sub.1 and R.sub.9 is a group independently selected from hydrido, methyl, ethyl, n-propyl, isopropyl, benzyl, .beta.,.beta.,.beta.-trifluoroethyl, t-butyloxycarbonyl and methoxymethylcarbonyl, and wherein the nitrogen atom to which R.sub.1 and R.sub.9 are attached may be combined with oxygen to form an N-oxide; wherein R.sub.2 is selected from hydrido, methyl, ethyl and isopropyl; wherein R.sub.3 is selected from benzyl, cyclohexylmethyl, phenethyl, imidazolemethyl, pyridylmethyl and 2-pyridylethyl; wherein each of R.sub.5 and R.sub.8 is independently propargyl or a propargyl-containing moiety; wherein R.sub.7 is cyclohexylmethyl; wherein each of R.sub.4 and R.sub.6 is independently selected from hydrido and methyl; wherein each of R.sub.11 and R.sub.12 is independently selected from hydrido, alkyl and phenyl; wherein m is zero; and wherein n is a number selected from zero through three; or a pharmaceutically-acceptable salt thereof.

REFERENCES:
patent: 4902706 (1990-02-01), Hanson et al.
patent: 5032577 (1991-07-01), Fung et al.
Umezawa et al., in J. Antibiot. (Tokyo), 23, 259-262 (1970).
Gross et al., Science, 175, 656 (1971).
Boger et al., Nature, 303, 81 (1983).
Kokubu et al., Biochm. Biophys. Res. Commun., 118, 929 (1984).
Castro et al., FEBS Lett., 167, 273 (1984).
Hanson et al., Biochm. Biophys. Res. Comm., 132, 155-161 (1985), 146, 959-963 (1987).

Affiliated with

Also associated with

Rating

Propargyl glycine amino propargyl diol compounds for treatment o does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Propargyl glycine amino propargyl diol compounds for treatment o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Propargyl glycine amino propargyl diol compounds for treatment o will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1755824